ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,099.96
      1.02%
      US Tech 100
      17,244.00
      1.57%
      Dow Jones
      38,239.66
      0.40%
      Brent Oil
      88.165
      0.00%
      Bitcoin
      63,360.87
      -0.59%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Mirati Therapeutics Inc (MRTX)

      7. Mirati Therapeutics Inc (MRTX) News

      MRTX Mirati Therapeutics Inc

      58.70
      0.00 (0.00%)
      Apr 25 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Mirati Therapeutics Inc MRTX NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 58.70 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      58.70 58.70
      more quote information »

      Recent News

      Date Time Source Heading
      2/14/202414:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/14/202409:13EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/02/202416:05EDGAR2Form 15-12G - Securities registration termination [Section..
      1/25/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
      1/23/202420:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/23/202420:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/23/202420:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/23/202420:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/23/202420:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/23/202420:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/23/202420:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/23/202409:31EDGAR2Form S-8 POS - Securities to be offered to employees in..
      1/23/202409:30EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
      1/23/202409:28EDGAR2Form POS AM - Post-Effective amendments for registration..
      1/23/202409:27EDGAR2Form POS AM - Post-Effective amendments for registration..
      1/23/202408:48EDGAR2Form 8-K - Current report
      1/18/202416:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/18/202416:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/10/202408:00PRNUSEuropean Commission Approves KRAZATI (adagrasib) as a..
      1/09/202417:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/05/202417:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/03/202418:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/03/202418:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/03/202418:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/03/202418:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/03/202418:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/03/202417:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/03/202417:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/27/202316:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      12/19/202316:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/19/202307:30EDGAR2Form 8-K - Current report
      12/14/202317:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/13/202316:30EDGAR2Form 8-K - Current report
      12/06/202308:29EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      12/01/202316:43EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      11/24/202316:45EDGAR2Form 8-K - Current report
      11/15/202308:49EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      11/10/202307:30PRNUSMirati Therapeutics Receives Positive Opinion from CHMP for..
      11/06/202308:05EDGAR2Form 8-K - Current report
      11/06/202308:00PRNUSMirati Therapeutics Reports Third Quarter 2023 Financial..
      11/06/202307:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/03/202317:19PRNUSMirati Therapeutics Receives Approval from the MHRA for..
      11/02/202307:30EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
      11/02/202307:30GLOBEKura Oncology and Mirati Therapeutics Enter into Clinical..
      10/23/202317:31EDGAR2Form PREM14A - Preliminary proxy statements relating to..
      10/17/202316:00PRNUSMirati Presents Late-Breaking Results Evaluating the..
      10/11/202307:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      10/10/202307:35EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      10/10/202307:33EDGAR2Form 8-K - Current report
      10/10/202307:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..

      Your Recent History

      NASDAQ
      MRTX
      Mirati Therapeutics
      Delayed Upgrade Clock